OKYO Pharma Limited (OKYO)
NASDAQ: OKYO
· Real-Time Price · USD
2.63
-0.01 (-0.38%)
At close: Aug 15, 2025, 3:59 PM
2.65
0.60%
After-hours: Aug 15, 2025, 04:10 PM EDT
OKYO Pharma Balance Sheet Statement
Financials in USD. Fiscal
year is
April - March.
| Fiscal Year | Q4 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 |
| Period Ending | Mar 31, 2025 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Sep 30, 2021 | Mar 31, 2021 | Sep 30, 2020 |
Cash & Equivalents | 1.56M | 987.2K | 987.2K | 826.85K | n/a | n/a | 4.05M | 3.35M | 707.57K | 633.63K | 2.7M | 5.17M | 6.89M | 7.41M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | -4.05M | 0.00 | n/a | -0.00 | n/a | n/a | n/a | n/a | n/a |
Receivables | 1.89M | 1.52M | n/a | 580.94K | n/a | n/a | 980.08K | n/a | -165.44K | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | 170.31K | n/a | 4.7K | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | n/a | 4.5K | 1.52M | n/a | n/a | n/a | n/a | 810.74K | 516.2K | 487.88K | n/a | 238.14K | 76.28K | 50.14K |
Total Current Assets | 3.68M | 2.83M | 2.83M | 1.54M | n/a | 4.05M | 5.2M | 4.3M | 1.77M | 1.58M | 4.3M | 5.52M | 6.99M | 7.48M |
Property-Plant & Equipment | 2.04K | 2.16K | 2.16K | 3.35K | n/a | n/a | 7.22K | 5.97K | 5.62K | 5.03K | 5.22K | 85.8K | 104.64K | 30.29K |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 2.04K | 2.16K | 2.16K | 3.35K | n/a | -4.05M | 7.22K | 5.97K | 5.62K | 5.03K | 5.22K | 85.8K | 104.64K | 30.29K |
Total Assets | 3.68M | 2.83M | 2.83M | 1.54M | n/a | n/a | 5.2M | 4.3M | 1.77M | 1.59M | 4.3M | 5.61M | 7.09M | 7.51M |
Account Payables | 7.9M | 9.61M | 9.61M | 6.13M | n/a | n/a | 1.02M | 1.98M | 1.24M | 1.36M | 517.67K | 215.56K | 210.99K | 213.44K |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.94 |
Short-Term Debt | n/a | 1.81K | 1.81K | n/a | n/a | n/a | 1.8M | 1.83M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | n/a | 445.63K | 445.63K | n/a | n/a | n/a | 1.71M | n/a | 284.74K | 0.00 | 323.06K | 339.48K | 1.46M | 154.16K |
Total Current Liabilities | 9.23M | 10.05M | 10.05M | 7.42M | n/a | n/a | 7.26M | 6M | 2.12M | 1.9M | 1.35M | 617.29K | 1.71M | 417.07K |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | 2.05M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | 2.05M | n/a | n/a | n/a | n/a | n/a | 47.12K | 64.61K | 23.83K |
Total Liabilities | 9.23M | 10.05M | 10.05M | 7.42M | n/a | 2.05M | 7.26M | 6M | 2.12M | 1.9M | 1.35M | 664.41K | 1.77M | 440.91K |
Total Debt | n/a | 1.81K | 1.81K | n/a | n/a | n/a | 2.22M | 1.83M | n/a | n/a | n/a | 81.55K | 98.76K | 28.97K |
Common Stock | 146.72M | n/a | n/a | 143.11M | n/a | n/a | 131.39M | n/a | 87.85M | n/a | 123.98M | 102.54M | 111.63M | 86.36M |
Retained Earnings | -143.02M | -145.2M | -145.2M | -142.52M | n/a | n/a | -125.7M | -103.98M | -90.9M | -81.4M | -112.43M | -99.97M | -106M | -90.55M |
Comprehensive Income | -11.47M | -6.07M | -6.07M | -11.31M | n/a | -2.05M | -11.45M | -6.4M | -58.34K | 2.43M | -11.01M | n/a | n/a | n/a |
Shareholders Equity | -5.55M | -7.23M | -7.23M | -5.88M | n/a | -2.05M | -2.05M | -1.7M | -345.82K | -309.68K | 2.95M | 4.94M | 5.32M | 7.07M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |